{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:48:42Z","timestamp":1790516922412,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005891","name":"Shandong Provincial Administration of Traditional Chinese Medicine of China","doi-asserted-by":"publisher","award":["2017-166"],"award-info":[{"award-number":["2017-166"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijantimicag.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T15:26:22Z","timestamp":1570634782000},"page":"105804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence"],"prefix":"10.1016","volume":"55","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The changing epidemiology of invasive fungal infections","volume":"1508","author":"Enoch","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/21505594.2014.1000752","article-title":"Looking into Candida albicans infection, host response, and antifungal strategies","volume":"6","author":"Wang","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0003","first-page":"2173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bjm.2015.11.008","article-title":"Azole resistance in Candida spp. isolated from Cat\u00fa Lake, Cear\u00e1, Brazil: an efflux-pump-mediated mechanism","volume":"47","author":"Brilhante","year":"2016","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0005","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.chembiol.2010.07.014","article-title":"Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases","volume":"17","author":"Gollapalli","year":"2010","journal-title":"Chem Biol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0006","doi-asserted-by":"crossref","first-page":"40320","DOI":"10.1074\/jbc.M407121200","article-title":"Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design","volume":"279","author":"Umejiego","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0007","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/13543776.2017.1280463","article-title":"Inosine-5\u2032-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002\u20132016)","volume":"27","author":"Cuny","year":"2017","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002957","article-title":"De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans","volume":"8","author":"Morrow","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0009","doi-asserted-by":"crossref","first-page":"e87246","DOI":"10.1371\/journal.pone.0087246","article-title":"Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B","volume":"9","author":"Banerjee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0010","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1074\/jbc.M409847200","article-title":"The functional basis of mycophenolic acid resistance in Candida albicans IMP dehydrogenase","volume":"280","author":"Kohler","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0011","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","year":"2017"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0012","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard\u2014third edition","year":"2008"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0013","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-4939-3052-4_13","article-title":"Microbroth dilution susceptibility testing of Candida species","volume":"1356","author":"Kuykendall","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0015","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","article-title":"Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms","volume":"45","author":"Ramage","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0016","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1128\/AAC.00676-07","article-title":"Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species","volume":"51","author":"Melo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0017","first-page":"76","article-title":"Candida tropicalis affects the virulence profile of Candida albicans: an in vitro and in vivo study","author":"de Barros","year":"2018","journal-title":"Pathog Dis"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0018","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1439-0507.2011.02024.x","article-title":"Correlation between phospholipase of Candida albicans and resistance to fluconazole","volume":"55","author":"Ying","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0019","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1099\/00221287-147-4-879","article-title":"The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans","volume":"147","author":"Hube","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/08927014.2015.1077383","article-title":"Effect of 2, 4-di-tert-butylphenol on growth and biofilm formation by an opportunistic fungus Candida albicans","volume":"31","author":"Padmavathi","year":"2015","journal-title":"Biofouling"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0021","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3855\/jidc.5359","article-title":"Investigation of the relationship between virulence factors and genotype of Candida spp. isolated from blood cultures","volume":"9","author":"Mutlu Sariguzel","year":"2015","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0022","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/AAC.03046-15","article-title":"The synergistic effect of azoles and fluoxetine against resistant Candida albicans strains is attributed to attenuating fungal virulence","volume":"60","author":"Gu","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1038\/npjbiofilms.2015.12","article-title":"A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance","volume":"1","author":"Pierce","year":"2015","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0024","doi-asserted-by":"crossref","first-page":"e41624","DOI":"10.1371\/journal.pone.0041624","article-title":"Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1139\/cjm-2018-0337","article-title":"The synergistic antifungal effects of sodium phenylbutyrate combined with azoles against Candida albicans via the regulation of the Ras-cAMP-PKA signalling pathway and virulence","volume":"65","author":"Sun","year":"2019","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0026","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fcimb.2017.00124","article-title":"Ambroxol hydrochloride combined with fluconazole reverses the resistance of Candida albicans to fluconazole","volume":"7","author":"Li","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mycmed.2017.01.006","article-title":"Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature","volume":"27","author":"Rezai","year":"2017","journal-title":"J Mycol Med"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0028","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jgar.2017.12.011","article-title":"Fluconazole inhibits cellular ergosterol synthesis to confer synergism with berberine against yeast cells","volume":"13","author":"Yang","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0029","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.pathol.2017.10.019","article-title":"Routine susceptibility testing for Candida albicans isolated from blood stream infections","volume":"50","author":"Choudhury","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0030","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1016\/j.bmc.2018.09.004","article-title":"Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles","volume":"26","author":"Kummari","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0031","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4161\/viru.22493","article-title":"Galleria mellonella as a model host for human pathogens: recent studies and new perspectives","volume":"3","author":"Junqueira","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0032","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1248\/bpb.b13-00270","article-title":"Using Galleria mellonella\u2013Candida albicans infection model to evaluate antifungal agents","volume":"36","author":"Li","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0033","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tim.2011.07.004","article-title":"Importance of Candida\u2013bacterial polymicrobial biofilms in disease","volume":"19","author":"Harriott","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0034","first-page":"328","article-title":"Oral candidosis\u2014clinical challenges of a biofilm disease","volume":"37","author":"Rautemaa","year":"2011","journal-title":"Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00294-013-0400-3","article-title":"Recent insights into Candida albicans biofilm resistance mechanisms","volume":"59","author":"Mathe","year":"2013","journal-title":"Curr Genet"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0036","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019729","article-title":"Fungal biofilms, drug resistance, and recurrent infection","volume":"4","author":"Desai","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0037","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fmed.2018.00028","article-title":"Candida biofilms: threats, challenges, and promising strategies","volume":"5","author":"Cavalheiro","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0038","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0039","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.micro.61.080706.093341","article-title":"Morphogenesis in Candida albicans","volume":"61","author":"Whiteway","year":"2007","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2004.05.008","article-title":"The distinct morphogenic states of Candida albicans","volume":"12","author":"Sudbery","year":"2004","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0041","first-page":"57","article-title":"Selected pathogenic characteristics of fungi from the genus Candida","volume":"59","author":"Modrzewska","year":"2013","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0042","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/eri.11.152","article-title":"Candida albicans dimorphism as a therapeutic target","volume":"10","author":"Jacobsen","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0043","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1099\/00222615-48-7-671","article-title":"Role of dimorphism in the development of Candida albicans biofilms","volume":"48","author":"Baillie","year":"1999","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0044","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.2741\/3224","article-title":"Secreted proteins of Candida albicans","volume":"13","author":"Hruskova-Heidingsfeldova","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0045","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/AAC.46.9.3096-3100.2002","article-title":"Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro","volume":"46","author":"Ripeau","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0046","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2180-10-114","article-title":"Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression","volume":"10","author":"Nailis","year":"2010","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0047","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1128\/AAC.01252-16","article-title":"A combination fluorescence assay demonstrates increased efflux pump activity as a resistance mechanism in azole-resistant vaginal Candida albicans isolates","volume":"60","author":"Bhattacharya","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0048","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1556\/amicr.54.2007.3.1","article-title":"Pathogenicity and drug resistance in Candida albicans and other yeast species. A review","volume":"54","author":"Mishra","year":"2007","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0049","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1128\/AAC.40.12.2835","article-title":"Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance","volume":"40","author":"Albertson","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0050","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1099\/00221287-146-11-2743","article-title":"A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole","volume":"146","author":"Calabrese","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/j.ijantimicag.2019.09.008_bib0051","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijantimicag.2017.09.012","article-title":"Gentamicin synergises with azoles against drug-resistant Candida albicans","volume":"51","author":"Lu","year":"2018","journal-title":"Int J Antimicrob Agents"}],"updated-by":[{"DOI":"10.1016\/j.ijantimicag.2020.105917","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000}}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T15:55:32Z","timestamp":1656863732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919302511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0924857919302511"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.008","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijantimicag.2020.105917","asserted-by":"object"}]},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105804"}}